- Home
- DXCM vs CNC Comparison
DXCM vs CNC Comparison
Compare DXCM & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXCM | CNC |
|---|---|---|
| Founded | 1999 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5B | 21.5B |
| IPO Year | 2005 | 2001 |
Fundamental Metrics
Financial Performance| Metric | DXCM | CNC |
|---|---|---|
| Price | $64.72 | $38.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 21 | 17 |
| Target Price | ★ $85.33 | $41.94 |
| AVG Volume (30 Days) | 3.6M | ★ 4.6M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.18 | N/A |
| EPS | ★ 2.09 | N/A |
| Revenue | N/A | ★ $194,777,000,000.00 |
| Revenue This Year | $14.46 | $8.31 |
| Revenue Next Year | $12.31 | $1.05 |
| P/E Ratio | $30.54 | ★ N/A |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $54.11 | $25.08 |
| 52 Week High | $89.07 | $63.42 |
Technical Indicators
Market Signals| Indicator | DXCM | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 48.95 | 56.13 |
| Support Level | $63.72 | $37.25 |
| Resistance Level | $69.18 | $39.61 |
| Average True Range (ATR) | 2.00 | 1.19 |
| MACD | 0.23 | 0.60 |
| Stochastic Oscillator | 66.95 | 82.10 |
Price Performance
Historical ComparisonAbout DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.